Riskpilot← Back to searchSign inGet full accessTR-H AS
ASActiveOrg 992993987Vettaliveien 4E, 0781 OsloRetail sale of pharmaceutical products · NACE 4773Est. 20081 employees
Revenue 2024
NOK 250K
EBITDA margin
61.7%
+135% vs 2023
Equity ratio
48.5%
Financial strength
Net profit 2024
NOK 18,6M
+227% vs 2023
| Revenue | NOK 250K | — |
| EBITDA | NOK 154K | +135% |
| Net profit | NOK 18,6M | +227% |
| Total assets | NOK 31,1M | +101% |
| Equity | NOK 15,1M | -2% |
| Employees | 1 | — |
Legal name
TR-H AS
Org number
992993987
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
19. august 2008
Share capital
NOK 110 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie å drive eiendom og apotek og alt hva hermed står i forbindelse med samt selge farmasøytiske tjenester og andre helserelaterte tjenester samt veiledning innen idrett. Selskapet skal også kunne investere i aksjer i andre selskaper.
Address
Vettaliveien 4E, 0781 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 20 | 242 | 55 | 0 | 250 |
| Staff expenses | −274 | −284 | −218 | −155 | −1 |
| EBITDA | −501 | −632 | −427 | −446 | 154 |
| Depreciation & amort. | −169 | −169 | −176 | −133 | −9 |
| EBIT | −670 | −800 | −604 | −579 | 145 |
| Net financials | 5 695 | −1 204 | 921 | 6 274 | 18 500 |
| Profit before tax | 5 026 | −2 004 | 318 | 5 695 | 18 645 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 5 026 | −2 004 | 318 | 5 695 | 18 645 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 14 482 | 12 470 | 11 770 | 15 449 | 31 069 |
| Equity | 14 407 | 11 403 | 10 720 | 15 416 | 15 061 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 75 | 1 067 | 1 050 | 33 | 16 009 |
| Total debt | 75 | 1 067 | 1 050 | 33 | 16 009 |
EBITDA margin
61.7%
This company
15.8%
Market median
+291% vs market
20202024
Equity ratio
48.5%
This company
38.2%
Market median
+27% vs market
20202024
Return on equity
123.8%
This company
18.4%
Market median
+573% vs market
20202024
Net profit margin
7458.0%
This company
8.1%
Market median
+91974% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2018 | |
| Chairman | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TR-H AS (this company)
SKIPPERGATA APOTEK ASBoard members of TR-H AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svanhild Teigen Rasch-Halvorsen | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Chairman | 0 companies |